Medical prescriptions to premature and newborn infants in an austrian neonatal intensive care unit;Verschreibepraxis von Arzneimitteln bei Früh- und Neugeborenen auf einer österreichischen neonatologischen Intensivstation

Klinische Padiatrie

Volumn 221, Issue 5, 2009, Pages 312-317

  Prandstetter, C ^a   Tamesberger, M ^a   Wagner, O ^a   Weissensteiner, M ^a   Wiesinger Eidenberger, G ^a   Weidinger, I ^a   Lechner, E ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Drugs; Medicines; Neonatology; Off label; Unlicenced

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; EXTREMELY LOW BIRTH WEIGHT; HEART SURGERY; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEWBORN; NEWBORN INTENSIVE CARE; OFF LABEL DRUG USE; PREMATURITY; PRESCRIPTION; RETROSPECTIVE STUDY;

AUSTRIA; DRUG APPROVAL; DRUG UTILIZATION; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; LENGTH OF STAY; MALE; OFF-LABEL USE; PRESCRIPTION DRUGS; UTILIZATION REVIEW;

EID: 77949754501     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1220903     Document Type: Article

References (27)

1. Amtsblatt der Europäischen Union. 16.12.2006, L378/1. Verordnung (EG) Nr. 1901/2006 des Europäischen Parlaments und des Rates vom 12. Dezember 2006 über Kinderarzneimittel und zur Änderung der Verordnung (EWG) Nr. 1768/92, der Richtlinien 2001/20/EG und 2001/83/EG sowie der Verordnung (EG) Nr. 726/2004
2. Assion HJ, Jungck C. Off-label prescribing in a German psychiatric hospital. Pharmacopsychiatry 2007 40 30-36
3. Austria-Codex. Fachinformation 2007/2008, Autor: Wolfgang Jasek, Ã-sterreichische Apotheker- VerlagsgesellschaftDatenbestand Austria Codex (CD-Rom) per 1.7.2008, Ã-sterreichische Apotheker-Verlagsgesellschaft m.b.H.
4. Avenel S, et al. The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr 2000 7 143-147
5. Barr J, et al. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am J Perinatol 2002 19 67-72
6. Benninger-Döring G, Boos J. Drug development in paediatric oncology. Klin Padiatr 2006 218 152-156
7. Bücheler R, et al. Off-label prescribing of drugs in the ambulatory care of children and adolescents. Dtsch Med Wochenschr 2002 Nov 29 127 2551-2557
8. Choonara I, Conroy S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf 2002 25 1-5
9. Committee on Drugs. American Academy of Pediatrics. Uses of drugs not described in the package insert (off-label uses). Pediatrics 2002 110 (1) 181-183
10. Conroy S, et al. Survey of unlicensed and off-label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 2000 320 79-82
11. Conroy S, et al. Unlicensed and off-label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999 80 F142-144 discussion F1445
12. Conroy S, et al. Unlicensed and off-label drug use in acute lymphoblastic leukaemia and other malignancies in children. Ann Oncol 2003 14 (1) 42-47
13. Cuzzolin L, et al. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 2006 5 703-718
14. DellAera M, et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 2007 29 361-367
15. Gortner L. Drug utilisation in preterm and term neonates: a neglected research area? Klin Padiatr 2008 220 219-220
16. Hoppu K. Paediatric clinical pharmacology: at the beginning of a new era. Eur J Clin Pharmacol 2008 64 201-205
17. Knöppel C, et al. Anwendung von Medikamenten außerhalb der Zulassung oder ohne Zulassung bei Kindern. Monatsschr Kinderheilkd 2000 148 904-908
18. Lampert ML, et al. Use of off-label and unlicensed drugs in the intensive care units of a paediatric university hospital in Switzerland. Gsasa News 2004 18 36-38
19. LÃpez MartÃ-nez R, et al. Drug use in a neonatal ICU: a prospective study. Farm Hosp 2005 29 26-29
20. Neubert A, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 2004 27 1059-1067
21. ODonnell CP, et al. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002 110 e52
22. Ohmann C. Clinical studies in pediatrics: challenges and actual developments. Klin Padiatr 2008 220 221-223
23. Poetsch J. Legal issues in the off-label use of drug medication in in pediatrics. J Dtsch Dermatol Ges 2006 4 421-426
24. Shirkey H. Therapeutic orphans. J Pediatr 1968 72 119-120
25. Turner S, et al. Use of off-label and unlicensed drugs in paediatric intensive care unit. Lancet 1996 347 549-550
26. Turner S, et al. Unlicensed and off-label drug use in paediatric wards: prospective study. BMJ 1998 316 343-345
27. Ufer M, et al. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 2004 13 147-152